Cases & Deals

Baxter acquires Claris Injectables

Clients Baxter International Inc.

Jones Day served as antitrust counsel to Baxter International Inc. in its acquisition of generic pharmaceuticals company Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.